Aeropine Eye Drop contains Atropine 1% w/v, a high-potency mydriatic used for precise pupil dilation in ophthalmic examinations, surgical interventions, and therapeutic procedures. Its reliable formulation ensures controlled and safe dilation, enhancing clinical accuracy.
The drop acts by relaxing the iris sphincter muscles, enabling comprehensive retina exams, detailed eye evaluations, and targeted treatment procedures. This supports both patient comfort and procedural efficiency in clinical settings.
For pharma franchise partners, Aeropine Eye Drop is a high-demand ophthalmic product regularly prescribed in eye hospitals, clinics, and diagnostic centers, providing steady sales, repeat orders, and strong prescriber trust.
Integrating Aeropine Eye Drop into your portfolio strengthens the ophthalmic care segment, offering long-term growth, enhanced portfolio credibility, and an edge in the competitive eye care market for franchise distributors.
Patients may experience temporary blurred vision, light sensitivity, stinging, burning sensation, or mild eye irritation. Rarely, systemic effects like dry mouth, flushing, increased heart rate, or allergic reactions may occur.
Aeropine Eye Drop is primarily indicated for managing amblyopia, uveitis, and other conditions requiring pupil dilation. It is also used during diagnostic procedures such as refraction testing or fundoscopy, where temporary mydriasis is necessary for accurate examination.
Use only under the guidance of an ophthalmologist. Avoid contact between the dropper tip and the eye to prevent contamination. Do not use in infants without medical supervision. Limit prolonged use to prevent systemic absorption. Seek immediate medical attention if severe eye irritation, allergic reactions, or unusual systemic symptoms develop.
Store in a cool, dry place below 25°C. Keep away from direct sunlight, tightly close the bottle after use, and keep out of reach of children. Do not use after the expiry date.